Page last updated: 2024-09-03

p(1),p(5)-di(adenosine-5'-)pentaphosphate and nickel

p(1),p(5)-di(adenosine-5'-)pentaphosphate has been researched along with nickel in 2 studies

Compound Research Comparison

Studies
(p(1),p(5)-di(adenosine-5'-)pentaphosphate)
Trials
(p(1),p(5)-di(adenosine-5'-)pentaphosphate)
Recent Studies (post-2010)
(p(1),p(5)-di(adenosine-5'-)pentaphosphate)
Studies
(nickel)
Trials
(nickel)
Recent Studies (post-2010) (nickel)
21522624,7773829,504

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Assmann, G; Löwe, S; Nofer, JR; Schlüter, H; Tepel, M; Zidek, W1
Bustamante, C; de Terreros, FJ; Díaz-Hernández, M; Gualix, J; Miras-Portugal, MT; Pintor, J1

Other Studies

2 other study(ies) available for p(1),p(5)-di(adenosine-5'-)pentaphosphate and nickel

ArticleYear
Diadenosine polyphosphates regulate cytosolic calcium in human fibroblast cells by interaction with P2x purinoceptors coupled to phospholipase C.
    Biochimica et biophysica acta, 1996, Jun-13, Volume: 1312, Issue:2

    Topics: Bridged-Ring Compounds; Calcium; Calcium Channel Blockers; Cells, Cultured; Cytosol; Dinucleoside Phosphates; Fibroblasts; Fura-2; Humans; Manganese; Nickel; Norbornanes; Phosphodiesterase Inhibitors; Purinergic Antagonists; Receptors, Purinergic; Suramin; Theobromine; Thiocarbamates; Thiones; Type C Phospholipases; Vasoconstrictor Agents; Verapamil; Xanthines

1996
Presence of dinucleotide and ATP receptors in human cerebrocortical synaptic terminals.
    European journal of pharmacology, 1999, Feb-05, Volume: 366, Issue:2-3

    Topics: Adenosine Triphosphate; Animals; Binding, Competitive; Calcium; Calcium Channel Blockers; Cerebral Cortex; Dinucleoside Phosphates; Humans; In Vitro Techniques; Inosine Nucleotides; Membrane Potentials; Nicardipine; Nickel; Presynaptic Terminals; Purinergic P2 Receptor Antagonists; Pyridoxal Phosphate; Rabbits; Receptors, Purinergic P1; Receptors, Purinergic P2; Synaptosomes; Vasoconstrictor Agents; Venoms

1999